10 research outputs found
Topical issues concerning treatment of intracellular bacterial pathogens in children
M.S. Savenkova1,2, M.P. Savenkov1
1Pirogov Russian National Research Medical University, Moscow, Russian Federation
2Morozov Childrenβs City Clinical Hospital, Moscow, Russian Federation
The article considers the issues of pharmacodynamics, clinical efficacy and safety of macrolide antibiotics. It also discusses the development of microorganisms resistance to macrolides. A number of studies in vivo and in vitro on various cellular and animal models have shown that macrolides have anti-inflammatory and immunomodulatory effects. The presence of these effects in macrolides may be especially relevant during the period of increasing incidence of influenza and the new COVID-19 coronavirus infection. It is known that the severity of viral infections is associated with the release of proinflammatory cytokines. Macrolides change the entire inflammatory response cascade by weakening the excess production of cytokines. Besides, macrolides can affect the activity of phagocytes, changing their function, including chemotaxis, phagocytosis, destroying bacteria and viruses. Earlier it was reported that macrolides (in particular, clarithromycin) can interfere with the replication cycle of the influenza virus, thus leading to its production inhibition by intracellular proteolysis of hemagglutinin. One of the commonly prescribed drugs in this group is clarithromycin. The article summarizes the literature data and presents the materials of our own clinical observations on the clarithromycin treatment of children with intracellular bacterial pathogens, the causative agents of which are Mycoplasma pneumoniae and Chlamydia pneumoniae.
Keywords: macrolides, clarithromycin, intracellular bacterial pathogens, children, antibacterial therapy.
For citation: Savenkova M.S., Savenkov M.P. Topical issues concerning treatment of intracellular bacterial pathogens in children. Russian Journal of Woman and Child Health. 2020;3(4):326β335. DOI: 10.32364/2618-8430-2020-3-4-326-335.
</p
TREATMENT OF FREQUENTLY SICK CHILDREN WITH MIXED INFECTION
The article presents information on treatment of children with frequent mixed infections (herpes-viral and intracellular). Examination of frequently sick children included combination of diagnostic methods (microbiological, serological) for the selection of combined therapy. Inosine pranobex (Isoprinosine) used as a part of complex treatment of mixed infection in frequently sick children favored to decrease of the duration of main clinical symptoms and to elimination of antibodies to infectious agents in respiratory tract or to decrease of their titre in most frequently sick children. Good therapeutic effect was detected in children with herpes viral infection.Key words: frequently sick children, respiratory infections, herpes virus, inosine pranobex, treatment.(Voprosy sovremennoi pediatrii β Current Pediatrics.Β 2011; 10 (4): 83β88
TREATMENT OF FREQUENTLY SICK CHILDREN WITH MIXED INFECTION
The article presents information on treatment of children with frequent mixed infections (herpes-viral and intracellular). Examination of frequently sick children included combination of diagnostic methods (microbiological, serological) for the selection of combined therapy. Inosine pranobex (Isoprinosine) used as a part of complex treatment of mixed infection in frequently sick children favored to decrease of the duration of main clinical symptoms and to elimination of antibodies to infectious agents in respiratory tract or to decrease of their titre in most frequently sick children. Good therapeutic effect was detected in children with herpes viral infection.Key words: frequently sick children, respiratory infections, herpes virus, inosine pranobex, treatment.(Voprosy sovremennoi pediatrii β Current Pediatrics.Β 2011; 10 (4): 83β88)</span
PROPHYLAXIS AND TREATMENT OF RESPIRATORY DISEASES AND FREQUENTLY AILING CHILDREN WITH TOPICAL BACTERIAL LYSATES
The share of acute respiratory infections is more than 90% of all diseases of upper airways. It mostly related with insufficiency of immunological defense, which elements are localized in different organs, including mucous tunic of upper airways. The article presents the data on high effectiveness of complex treatment of frequently ailing children with respiratory infection, including topical immunomodulator IRS 19 (bacterial lysates mixture). Its administration combined with antibiotics and antiviral medications allowed achieving more rapid fauces sanation. In particular, significant decreasing of pathogenic and conditionally pathogenic micro flora (neumococcus, neisseria, and Staphylococcus aureus) was marked in 3 months after the beginning of treatment.Key words: frequently ailing children, acute respiratory infections, etiotropic therapy, bacterial lysates mixture.(Voprosy sovremennoi pediatrii βΒ Current Pediatrics. 2009;8(6):92-96
PROPHYLAXIS AND TREATMENT OF RESPIRATORY DISEASES AND FREQUENTLY AILING CHILDREN WITH TOPICAL BACTERIAL LYSATES
The share of acute respiratory infections is more than 90% of all diseases of upper airways. It mostly related with insufficiency of immunological defense, which elements are localized in different organs, including mucous tunic of upper airways. The article presents the data on high effectiveness of complex treatment of frequently ailing children with respiratory infection, including topical immunomodulator IRS 19 (bacterial lysates mixture). Its administration combined with antibiotics and antiviral medications allowed achieving more rapid fauces sanation. In particular, significant decreasing of pathogenic and conditionally pathogenic micro flora (neumococcus, neisseria, and Staphylococcus aureus) was marked in 3 months after the beginning of treatment.Key words: frequently ailing children, acute respiratory infections, etiotropic therapy, bacterial lysates mixture.(Voprosy sovremennoi pediatrii βΒ Current Pediatrics. 2009;8(6):92-96)</span
Importance of herpes viruses in children with post-COVID conditions
M.S. Savenkova1,2, I.A. Sotnikov2, A.A. Afanasieva1,2, Ya.V. Afanasieva3, R.V. Dushkin4
1Pirogov Russian National Research Medical University, Moscow, Russian Federation
2Morozov Children's City Clinical Hospital, Moscow, Russian Federation
3All-Russian Public Organization βRussian Academy of Engineeringβ, Moscow, Russian Federation
4LLC βAgency of Artificial Intelligence,β Moscow, Russian Federation
Aim: to assess the prevalence of detection of confirmed herpes virus infections (HVI) in children who had a previous COVID-19 infection, characterize specific clinical manifestations of the disease under the new conditions (post-COVID syndrome), and to provide a rationale for the administration of drug therapy.
Patients and Methods: of 456 patients who received medical consultations from September 2021 to July 2022, the authors selected 72 (15.8%) children (42 boys and 30 girls) who had a previous SARS-CoV-2 infection confirmed by serological tests or polymerase chain reaction and in whom herpes viruses were found during serological evaluation.
Results: most of the children (81.4%) visited the polyclinic within the first six months after the COVID-19 infection. Epstein-Barr virus (EBV) was the most prevalent finding among herpesviruses detected in children with post-COVID-19 sequela β it was detected in 44 (61.1%) cases. Human herpesvirus (HHV) 6 and cytomegalovirus (CMV) were less common in this group and found in 41 (56.9%) and 30 (41.7%) children, respectively. HHV-1 and HHV-2 were detected more rarely β in 11 (15.3%) children. Monoinfection was diagnosed in 41 (56.9%) cases and a combination of viruses was found in 31 children, in 22 (71.0%) of them it comprised two viruses, in 6 (19.3%) β three viruses, and in 3 (9.7%) β four viruses. The presence of herpesvirus infections underpinned the main reasons why parents of the ill children were seeking for outpatient care, in particular: a prolonged subfebrile condition (18.0%), fatigue and sleep disorders (27.7%), rashes (16.6%), lymphadenopathy (16.7%), ENT diseases (33.3%), more frequently occurring respiratory diseases (33.3%), and the increase in seizure activity in children with epilepsy (8.3%). In addition to herpes viruses, pathogenic agents were detected in 18% of patients, including intracellular pathogens, which were found in 13.9% of 72 children. Taking into consideration the obtained results and established clinical diagnoses, the authors conducted a review and provided a rationale for the administered drug therapy, including medications for herpes treatment.
Conclusion: a prior COVID-19 infection induces immunosuppression and, as a result, the activation of herpesvirus infections as long-term effects of COVID-19 (post-COVID conditions). The presence of mixed viral and bacterial pathogens is an indication for administering antivirals, immunomodulators, antibacterial agents, and probiotics.
Keywords: post-COVID conditions, herpesvirus infections, children, clinical symptoms, treatment.
For citation: Savenkova M.S., Sotnikov I.A., Afanasieva A.A. et al. Importance of herpes viruses in children with post-COVID conditions. Russian Journal of Woman and Child Health. 2023;6(1):39β44 (in Russ.). DOI: 10.32364/2618-8430-2023-6-1-39-44.
<br
ΠΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΏΡΠΎΠ΄Π»Π΅Π½Π½ΠΎΠΉ Π°Π½Π°Π»Π³Π΅Π·ΠΈΠΈ ΠΏΠ»Π΅ΡΠ΅Π²ΠΎΠ³ΠΎ ΡΠΏΠ»Π΅ΡΠ΅Π½ΠΈΡ Π΄Π»Ρ ΡΠ°Π½Π½Π΅ΠΉ ΡΠ΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΠΈ Π΄Π΅ΡΠ΅ΠΉ Ρ ΠΏΠΎΡΡΡΡΠ°Π²ΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΊΠΎΠ½ΡΡΠ°ΠΊΡΡΡΠ°ΠΌΠΈ Π»ΠΎΠΊΡΠ΅Π²ΠΎΠ³ΠΎ ΡΡΡΡΠ°Π²Π°
Objective. Improvement of surgical treatment outcomes in children with post-traumatic elbow contractures. Materials and methods. The study is based on the diagnostic findings of 48 children with post-traumatic elbow contractures who were treated at the Turner Scientific and Research Institute for Childrens Orthopedics. All children underwent complex rehabilitation after reconstructive intra-articular surgery to work out passive motions in the elbow using ARTROMOT-E2 device. The patients of the study group started rehabilitation in the first days after reconstructive intra-articular surgery in the background of prolonged blockade of the brachial plexus. In the control group, the rehabilitation was carried out traditionally on the 6th day after surgery without regional anesthesia. The patients of the study group were supplied with Contiplex SU perinural catheters for prolonged blockade of the brachial plexus using ultrasound (Edge SonoSite) and neurostimulation (Stimuplex HNS12) before surgery. For perioperative blockade of the brachial plexus we used intermittent injection of 0.5% ropivacaine (2 mg / kg). The severity of pain at the stages of rehabilitation was assessed using 10-point grading scale (FPS-R). The range of active and passive motions in the joints was evaluated by measuring the range of motions with a fleximeter. Results. Intermittent injection of ropivacaine before rehabilitation allowed to correct post-traumatic elbow contractures in children in the first days after surgery associated with the minimum subjective pain level and stable hemodynamic parameteres, accompanied with a significant increase of the elbow motion range in comparison with the group of the patients who were not performed regional anesthesia . Conclusion. Prolonged blockade of the brachial plexus in rehabilitation treatment of children with post-traumatic contractures provides appropriate analgesic and myoneural block components from the 1st day after intra-articular reconstructive surgery. Early rehabilitation provides good results of the treatment and reduces rehabilitation period terms.Π¦Π΅Π»Ρ ΡΠ°Π±ΠΎΡΡ - ΡΠ»ΡΡΡΠ΅Π½ΠΈΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ Ρ Π΄Π΅ΡΠ΅ΠΉ Ρ ΠΏΠΎΡΡΡΡΠ°Π²ΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΊΠΎΠ½ΡΡΠ°ΠΊΡΡΡΠ°ΠΌΠΈ Π»ΠΎΠΊΡΠ΅Π²ΠΎΠ³ΠΎ ΡΡΡΡΠ°Π²Π°. ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΡΠΏΠΎΠ»Π½Π΅Π½ Π°Π½Π°Π»ΠΈΠ· ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ 48 Π΄Π΅ΡΠ΅ΠΉ Ρ ΠΏΠΎΡΡΡΡΠ°Π²ΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΊΠΎΠ½ΡΡΠ°ΠΊΡΡΡΠ°ΠΌΠΈ Π»ΠΎΠΊΡΠ΅Π²ΠΎΠ³ΠΎ ΡΡΡΡΠ°Π²Π°, ΠΊΠΎΡΠΎΡΡΠ΅ ΠΏΡΠΎΡ
ΠΎΠ΄ΠΈΠ»ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ Π² Π€ΠΠΠ£ ΠΠ°ΡΡΠ½ΠΎ-ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΡΠΊΠΈΠΉ Π΄Π΅ΡΡΠΊΠΈΠΉ ΠΎΡΡΠΎΠΏΠ΅Π΄ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΈΠ½ΡΡΠΈΡΡΡ ΠΈΠΌ. Π.Π. Π’ΡΡΠ½Π΅ΡΠ° ΠΠΈΠ½Π·Π΄ΡΠ°Π²Π° Π ΠΎΡΡΠΈΠΈ. ΠΡΠ΅ΠΌ Π΄Π΅ΡΡΠΌ ΠΏΠΎΡΠ»Π΅ ΡΠ΅ΠΊΠΎΠ½ΡΡΡΡΠΊΡΠΈΠ²Π½ΡΡ
Π²Π½ΡΡΡΠΈΡΡΡΡΠ°Π²Π½ΡΡ
ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΉ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡ ΡΠ΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΠΎΠ½Π½ΡΡ
ΠΌΠ΅ΡΠΎΠΏΡΠΈΡΡΠΈΠΉ, Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΡΡ
Π½Π° ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΡ ΠΏΠ°ΡΡΠΈΠ²Π½ΡΡ
Π΄Π²ΠΈΠΆΠ΅Π½ΠΈΠΉ Π² Π»ΠΎΠΊΡΠ΅Π²ΠΎΠΌ ΡΡΡΡΠ°Π²Π΅ Π½Π° Π°ΠΏΠΏΠ°ΡΠ°ΡΠ΅ ARTROMOT-E2. ΠΠ°ΡΠΈΠ΅Π½ΡΠ°ΠΌ ΠΎΡΠ½ΠΎΠ²Π½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΡ ΠΏΠ°ΡΡΠΈΠ²Π½ΡΡ
Π΄Π²ΠΈΠΆΠ΅Π½ΠΈΠΉ Π² Π»ΠΎΠΊΡΠ΅Π²ΠΎΠΌ ΡΡΡΡΠ°Π²Π΅ Π½Π°ΡΠΈΠ½Π°Π»ΠΈ Π½Π° ΡΠΎΠ½Π΅ ΠΏΡΠΎΠ΄Π»Π΅Π½Π½ΡΡ
Π±Π»ΠΎΠΊΠ°Π΄ ΠΏΠ»Π΅ΡΠ΅Π²ΠΎΠ³ΠΎ ΡΠΏΠ»Π΅ΡΠ΅Π½ΠΈΡ Π² ΠΏΠ΅ΡΠ²ΡΠ΅ ΡΡΡΠΊΠΈ ΠΏΠΎΡΠ»Π΅ ΡΠ΅ΠΊΠΎΠ½ΡΡΡΡΠΊΡΠΈΠ²Π½ΡΡ
Π²Π½ΡΡΡΠΈΡΡΡΡΠ°Π²Π½ΡΡ
ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΉ. Π ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΠ΅ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡ ΡΠ΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΠΎΠ½Π½ΡΡ
ΠΌΠ΅ΡΠΎΠΏΡΠΈΡΡΠΈΠΉ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ ΡΡΠ°Π΄ΠΈΡΠΈΠΎΠ½Π½ΠΎ - Ρ 6-Ρ
ΡΡΡΠΎΠΊ ΠΏΠΎΡΠ»Π΅ Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ²Π° Π±Π΅Π· ΡΠ΅Π³ΠΈΠΎΠ½Π°ΡΠ½ΠΎΠΉ Π°Π½Π°Π»Π³Π΅Π·ΠΈΠΈ. ΠΠ°ΡΠΈΠ΅Π½ΡΠ°ΠΌ ΠΎΡΠ½ΠΎΠ²Π½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ ΠΊΠ°ΡΠ΅ΡΠ΅ΡΡ Π΄Π»Ρ ΠΏΡΠΎΠ΄Π»Π΅Π½Π½ΠΎΠΉ Π±Π»ΠΎΠΊΠ°Π΄Ρ ΠΏΠ»Π΅ΡΠ΅Π²ΠΎΠ³ΠΎ ΡΠΏΠ»Π΅ΡΠ΅Π½ΠΈΡ Contiplex SU ΡΡΡΠ°Π½Π°Π²Π»ΠΈΠ²Π°Π»ΠΈ ΠΏΠ΅ΡΠΈΠ½Π΅Π²ΡΠ°Π»ΡΠ½ΠΎ Π½Π°Π΄ΠΊΠ»ΡΡΠΈΡΠ½ΡΠΌ Π΄ΠΎΡΡΡΠΏΠΎΠΌ ΠΏΠΎΠ΄ ΠΊΠΎΠ½ΡΡΠΎΠ»Π΅ΠΌ ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠ° (Edge SonoSite) ΠΈ Π½Π΅ΠΉΡΠΎΡΡΠΈΠΌΡΠ»ΡΡΠΈΠΈ (Stimuplex HNS 12) ΠΏΠΎΡΠ»Π΅ ΠΈΠ½Π΄ΡΠΊΡΠΈΠΈ Π² Π°Π½Π΅ΡΡΠ΅Π·ΠΈΡ ΠΏΠ΅ΡΠ΅Π΄ Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌ Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ²ΠΎΠΌ. ΠΠ΅ΡΠΈΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΡΡ Π±Π»ΠΎΠΊΠ°Π΄Ρ ΠΏΠ»Π΅ΡΠ΅Π²ΠΎΠ³ΠΎ ΡΠΏΠ»Π΅ΡΠ΅Π½ΠΈΡ ΠΎΠ±Π΅ΡΠΏΠ΅ΡΠΈΠ²Π°Π»ΠΈ ΠΈΠ½ΡΠ΅ΡΠΌΠΈΡΡΠΈΡΡΡΡΠΈΠΌ Π²Π²Π΅Π΄Π΅Π½ΠΈΠ΅ΠΌ 0,5% ΡΠ°ΡΡΠ²ΠΎΡΠ° ΡΠΎΠΏΠΈΠ²Π°ΠΊΠ°ΠΈΠ½Π° (2 ΠΌΠ³/ΠΊΠ³). ΠΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΡΡΡ Π±ΠΎΠ»ΠΈ Π½Π° ΡΡΠ°ΠΏΠ°Ρ
ΡΠ΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΠΈ ΠΎΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ ΠΏΠΎ 10-Π±Π°Π»Π»ΡΠ½ΠΎΠΉ Π»ΠΈΡΠ΅Π²ΠΎΠΉ ΡΠΊΠ°Π»Π΅ Π±ΠΎΠ»ΠΈ (FPS-R). ΠΠ±ΡΠ΅ΠΌ Π°ΠΊΡΠΈΠ²Π½ΡΡ
ΠΈ ΠΏΠ°ΡΡΠΈΠ²Π½ΡΡ
Π΄Π²ΠΈΠΆΠ΅Π½ΠΈΠΉ Π² ΡΡΡΡΠ°Π²Π°Ρ
ΠΎΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ Π°ΠΌΠΏΠ»ΠΈΡΡΠ΄Ρ Π΄Π²ΠΈΠΆΠ΅Π½ΠΈΠΉ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΡΠ³Π»ΠΎΠΌΠ΅ΡΠ°. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠ½ΡΠ΅ΡΠΌΠΈΡΡΠΈΡΡΡΡΠ΅Π΅ Π²Π²Π΅Π΄Π΅Π½ΠΈΠ΅ ΡΠΎΠΏΠΈΠ²Π°ΠΊΠ°ΠΈΠ½Π° ΠΏΠ΅ΡΠ΅Π΄ ΡΠ΅Π°Π½ΡΠΎΠΌ ΠΠ€Π ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΠ»ΠΎ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΡΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΡ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΡ ΠΏΠΎΡΡΡΡΠ°Π²ΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΊΠΎΠ½ΡΡΠ°ΠΊΡΡΡ Π»ΠΎΠΊΡΠ΅Π²ΠΎΠ³ΠΎ ΡΡΡΡΠ°Π²Π° Ρ Π΄Π΅ΡΠ΅ΠΉ Π² ΠΏΠ΅ΡΠ²ΡΠ΅ ΡΡΡΠΊΠΈ ΠΏΠΎΡΠ»Π΅ Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ²Π° ΠΏΡΠΈ ΠΌΠΈΠ½ΠΈΠΌΠ°Π»ΡΠ½ΠΎΠΌ ΡΡΠΎΠ²Π½Π΅ Π±ΠΎΠ»ΠΈ ΠΈ ΡΡΠ°Π±ΠΈΠ»ΡΠ½ΡΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΡ
Π³Π΅ΠΌΠΎΠ΄ΠΈΠ½Π°ΠΌΠΈΠΊΠΈ, ΡΡΠΎ ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΠΎΠ²Π°Π»ΠΎ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΡ Π°ΠΌΠΏΠ»ΠΈΡΡΠ΄Ρ Π΄Π²ΠΈΠΆΠ΅Π½ΠΈΠΉ Π² ΡΡΡΡΠ°Π²Π΅ ΠΈ ΡΠΎΠΊΡΠ°ΡΠ΅Π½ΠΈΡ ΡΡΠΎΠΊΠΎΠ² Π³ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΏΡΠΎΠ΄Π»Π΅Π½Π½ΡΡ
Π±Π»ΠΎΠΊΠ°Π΄ ΠΏΠ»Π΅ΡΠ΅Π²ΠΎΠ³ΠΎ ΡΠΏΠ»Π΅ΡΠ΅Π½ΠΈΡ Π² ΡΡΡΡΠΊΡΡΡΠ΅ Π°ΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π²ΠΎΡΡΡΠ°Π½ΠΎΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ Ρ Π΄Π΅ΡΠ΅ΠΉ Ρ ΠΏΠΎΡΡΡΡΠ°Π²ΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΊΠΎΠ½ΡΡΠ°ΠΊΡΡΡΠ°ΠΌΠΈ ΠΎΠ±Π΅ΡΠΏΠ΅ΡΠΈΠ²Π°Π΅Ρ Π°Π΄Π΅ΠΊΠ²Π°ΡΠ½ΡΠΉ Π°Π½Π°Π»Π³Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΈ ΠΌΠΈΠΎΠΏΠ»Π΅Π³ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ Π²ΠΎ Π²ΡΠ΅ΠΌΡ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ ΠΠ€Π Ρ ΠΏΠ΅ΡΠ²ΡΡ
ΡΡΡΠΎΠΊ ΠΏΠΎΡΠ»Π΅ ΡΠ΅ΠΊΠΎΠ½ΡΡΡΡΠΊΡΠΈΠ²Π½ΡΡ
Π²Π½ΡΡΡΠΈΡΡΡΡΠ°Π²Π½ΡΡ
Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ². Π Π°Π½Π½Π΅Π΅ Π½Π°ΡΠ°Π»ΠΎ ΡΠ΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΠΎΠ½Π½ΡΡ
ΠΌΠ΅ΡΠΎΠΏΡΠΈΡΡΠΈΠΉ ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΠΎ ΡΠΊΠ°Π·ΡΠ²Π°Π΅ΡΡΡ Π½Π° ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°Ρ
Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈ ΡΡΠΎΠΊΠ°Ρ
ΡΠ΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΠΈ
ACUTE EPIGLOTTITIS IN CHILDREN (ETIOPATHOGENESIS, DIAGNOSIS, TREATMENT)
Acute epiglottitis (AE) must be considered as not a separate entdisease but as compound pathology with wide polymorphism, which can often need an intervention of different medical specialists: experts in resuscitation, infectiologists, immunologists, pulmonologists, and cardiologists. The increase of rate of AE and its septic complications and severe outcomes in last years forced us to consider this problem in detail on the basis of longstanding experience of Morozov children's city clinical hospital.Key words: children, acute epiglottitis, etiology, diagnosis, treatment